More and more evidence has clarified the role of MMP-3 in IBD, especially the concentration of MMP3 that is critical for determining responsiveness to infliximab therapy in individuals diagnosed with IBD [123,124]. This evidence concerns the gene MMP3 and inflammatory bowel disease.